US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Alamar Biosciences

34.07

+1.424.35%

Post-market: 34.070.00000.00%19:30 EDT

Volume:741.82K

Turnover:25.27M

Market Cap:2.36B

PE:-47.58

High:35.28

Open:32.47

Low:32.24

Close:32.65

52wk High:38.54

52wk Low:18.85

Shares:69.31M

Float Shares:12.94M

Volume Ratio:1.49

T/O Rate:5.73%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.7160

EPS(LYR):-2.5873

ROE:-33.57%

ROA:-13.53%

PB:7.55

PE(LYR):-13.17

Loading ...

Overview Company News Filings

Nightingale Health Signs USD 6.5 Million Proteomics Services Deal with Michael J. Fox Foundation

Lancet study using Alamar’s technology reveals divergent responses to Alzheimers

Alamar Biosciences Says Lancet Neurology Study Tracks 130 Plasma Biomarkers in Real-World Lecanemab-Treated Alzheimer’s Patients

Lancet Neurology Study Using Alamar Biosciences’ Technology Reveals Divergent Biological Responses to Alzheimer’s Treatment

THOMSON REUTERS

US Research Roundup-Autozone, General Mills, JPMorgan

Alamar Biosciences Inc : Leerink Partners Raises Target Price to $45 from $35

THOMSON REUTERS

Alamar Biosciences rises 9.4%

Alamar Biosciences Director Robert P. Ragusa Files Initial Beneficial Ownership Statement

Alamar Biosciences Appoints Robert Ragusa to Board

Alamar Biosciences Price Target Raised to $32.00/Share from $28.00 by Stifel

Top Midday Gainers

MT Newswires Live

Alamar Biosciences Stock Soars, CEO Says Company Is Well-Positioned to Sustain Upcoming Momentum

Benzinga Earnings

Alamar Biosciences up over 18%, on Track for Record High Close and Record Percent Increase

BofA Adjusts Price Target on Alamar Biosciences to $31 From $30

MT Newswires Live

Alamar Biosciences price target raised to $32 from $28 at Stifel

U.S. Research Roundup-Accendra Health, Celestica, Sionna Therapeutics

Alamar Biosciences Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Alamar Biosciences Outlook FY Revenue $116 Mln-$120 Mln

THOMSON REUTERS

Alamar Biosciences reports Q2 EPS (22c), consensus (32c)

Alamar Biosciences sees FY26 revenue $116M-$120M, consensus $113.22M

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/ALMR/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALMR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALMR\",,,,,undefined,":{"symbol":"ALMR","market":"US","secType":"STK","nameCN":"Alamar Biosciences","latestPrice":34.07,"timestamp":1790798400000,"preClose":32.65,"halted":0,"volume":741823,"hourTrading":{"tag":"盘后","latestPrice":34.07,"preClose":34.07,"latestTime":"19:30 EDT","volume":4960,"amount":168991.7788,"timestamp":1790811003866,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.043491577335375245,"floatShares":12937500,"shares":69311200,"eps":-0.716,"marketStatus":"Not Yet Opened","change":1.42,"latestTime":"09-30 16:00:00 EDT","open":32.47,"high":35.28,"low":32.235,"amount":25271339.935128,"amplitude":0.093262,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.716,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1790841600000},"marketStatusCode":0,"adr":0,"listingDate":1776398400000,"exchange":"NASDAQ","adjPreClose":32.65,"preHourTrading":{"tag":"盘前","latestPrice":32.48,"preClose":32.65,"latestTime":"09:29 EDT","volume":903,"amount":29931.954107999998,"timestamp":1790774992043,"change":-0.17,"changeRate":-0.005207,"amplitude":0.048086},"postHourTrading":{"tag":"盘后","latestPrice":34.07,"preClose":34.07,"latestTime":"19:30 EDT","volume":4960,"amount":168991.7788,"timestamp":1790811003866,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.487872},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALMR\",,,,,undefined,":{"symbol":"ALMR","floatShares":12937500,"roa":"-13.53%","roe":"-33.57%","lyrEps":-2.587299,"volumeRatio":1.487872,"shares":69311200,"dividePrice":0,"high":35.28,"amplitude":0.093262,"preClose":32.65,"low":32.235,"week52Low":18.845,"pbRate":"7.55","psRate":"23.52","week52High":38.54,"institutionHeld":0,"latestPrice":34.07,"eps":-0.716,"divideRate":0,"volume":741823,"delay":0,"ttmEps":-0.716,"open":32.47,"prevYearClose":17,"prevWeekClose":32.8,"prevMonthClose":30.54,"prevQuarterClose":27.09,"fiveDayClose":32.14,"twentyDayClose":29.36,"sixtyDayClose":25.23},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALMR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-10","symbol":"ALMR","fiscalQuarterEnding":"2026/06","expectedEps":-0.36,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786334400000,"reportTimeType":"post","actualEps":-0.22}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALMR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALMR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.4,"hold":0.2,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4,"analysts":5,"updateTime":1779249600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALMR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALMR","date":"2026-09-29","current":-47.583799,"percent":0.292453,"low":-61.051551,"twenty":-46.413687,"median":-41.85001,"eighty":-35.066025,"high":-30.427746,"avg":-42.336494,"sd":7.26935,"marketCap":2262898099},"quantilePoints":[{"date":"2026-05-01","current":-57.277289,"twenty":-59.990183,"median":-57.277289,"eighty":-56.655108,"marketCap":1707951482},{"date":"2026-05-08","current":-54.120633,"twenty":-59.175857,"median":-56.408065,"eighty":-54.495772,"marketCap":1613823165},{"date":"2026-05-15","current":-35.878919,"twenty":-57.629553,"median":-54.669617,"eighty":-53.99338,"marketCap":1560194796},{"date":"2026-05-22","current":-35.066025,"twenty":-56.9113,"median":-54.440874,"eighty":-34.919385,"marketCap":1524846092},{"date":"2026-05-29","current":-31.495666,"twenty":-56.325717,"median":-53.802501,"eighty":-32.467951,"marketCap":1369589035},{"date":"2026-06-05","current":-34.253131,"twenty":-55.282649,"median":-35.878919,"eighty":-32.646469,"marketCap":1489497387},{"date":"2026-06-12","current":-35.368868,"twenty":-54.724515,"median":-34.699426,"eighty":-32.401007,"marketCap":1538015217},{"date":"2026-06-18","current":-32.196986,"twenty":-54.651317,"median":-34.308917,"eighty":-32.158732,"marketCap":1400085957},{"date":"2026-06-26","current":-42.828368,"twenty":-54.587269,"median":-35.066025,"eighty":-32.350002,"marketCap":1862391567},{"date":"2026-07-02","current":-41.648874,"twenty":-54.495772,"median":-35.368868,"eighty":-32.60184,"marketCap":1811101290},{"date":"2026-07-10","current":-42.206743,"twenty":-54.303628,"median":-36.436788,"eighty":-32.691099,"marketCap":1835360205},{"date":"2026-07-17","current":-39.76806,"twenty":-53.99338,"median":-39.098618,"eighty":-32.700662,"marketCap":1729314090},{"date":"2026-07-24","current":-41.266336,"twenty":-53.295956,"median":-39.903543,"eighty":-32.786733,"marketCap":1794466605},{"date":"2026-07-31","current":-39.959329,"twenty":-52.542305,"median":-39.576791,"eighty":-32.978002,"marketCap":1737631433},{"date":"2026-08-07","current":-44.788877,"twenty":-45.298929,"median":-40.039025,"eighty":-33.153333,"marketCap":1947644326},{"date":"2026-08-14","current":-46.000078,"twenty":-46.279543,"median":-40.206385,"eighty":-33.248967,"marketCap":2284409856},{"date":"2026-08-21","current":-48.403484,"twenty":-48.403484,"median":-40.899736,"eighty":-33.37648,"marketCap":2403765414},{"date":"2026-08-28","current":-46.111864,"twenty":-47.844552,"median":-41.354,"eighty":-34.253131,"marketCap":2289961278},{"date":"2026-09-04","current":-42.716354,"twenty":-47.62098,"median":-41.648874,"eighty":-34.285009,"marketCap":2121336856},{"date":"2026-09-11","current":-38.803832,"twenty":-46.592546,"median":-41.648874,"eighty":-34.323263,"marketCap":1927037111},{"date":"2026-09-18","current":-44.728508,"twenty":-46.290722,"median":-41.354,"eighty":-34.86838,"marketCap":2221262439},{"date":"2026-09-25","current":-46.39133,"twenty":-46.659617,"median":-41.648874,"eighty":-35.053274,"marketCap":2303839831},{"date":"2026-09-29","current":-45.566906,"twenty":-46.413687,"median":-41.85001,"eighty":-35.066025,"marketCap":2262898099}],"updateTime":1790839767011},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALMR\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672789136","title":"Nightingale Health Signs USD 6.5 Million Proteomics Services Deal with Michael J. Fox Foundation","url":"https://stock-news.laohu8.com/highlight/detail?id=2672789136","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672789136?lang=en_us&edition=fundamental","pubTime":"2026-10-01 01:11","pubTimestamp":1790788273,"startTime":"0","endTime":"0","summary":"Nightingale Health signs USD 6.5 million proteomics services deal with Michael J. Fox FoundationNightingale Health signed a USD 6.5 million proteomics services agreement with the Michael J. Fox Founda","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL3SvlPh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670166794","title":"Lancet study using Alamar’s technology reveals divergent responses to Alzheimers","url":"https://stock-news.laohu8.com/highlight/detail?id=2670166794","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670166794?lang=en_us&edition=fundamental","pubTime":"2026-09-25 07:00","pubTimestamp":1790290812,"startTime":"0","endTime":"0","summary":"The company states: “Alamar Biosciences (ALMR) announced the publication in The Lancet Neurology of the first longitudinal cohort study to evaluate...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lancet-study-using-alamars-technology-reveals-divergent-responses-to-alzheimers-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lancet-study-using-alamars-technology-reveals-divergent-responses-to-alzheimers-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670415065","title":"Alamar Biosciences Says Lancet Neurology Study Tracks 130 Plasma Biomarkers in Real-World Lecanemab-Treated Alzheimer’s Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2670415065","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670415065?lang=en_us&edition=fundamental","pubTime":"2026-09-25 06:51","pubTimestamp":1790290296,"startTime":"0","endTime":"0","summary":"Alamar Biosciences says Lancet Neurology study tracks 130 plasma biomarkers in real-world lecanemab-treated Alzheimer’s patientsAlamar Biosciences flagged a Lancet Neurology publication on a longitudi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL93F0nP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","BK4121","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BQXX3D17.EUR","SG9999014021.USD","SG9999014039.USD","BCDF","IE00BKPKM429.USD","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","ALMR","IE00BQXX3F31.USD","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","NDAQ","BK4112","BK4585","SG9999014013.SGD","BK4588","LU0314104364.USD","LU2210150020.SGD","LU2095319765.USD","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670150694","title":"Lancet Neurology Study Using Alamar Biosciences’ Technology Reveals Divergent Biological Responses to Alzheimer’s Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2670150694","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670150694?lang=en_us&edition=fundamental","pubTime":"2026-09-25 06:51","pubTimestamp":1790290279,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nTUA8TGNHK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669446870","title":"US Research Roundup-Autozone, General Mills, JPMorgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2669446870","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669446870?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:23","pubTimestamp":1790238235,"startTime":"0","endTime":"0","summary":"US RESEARCH ROUNDUP-Autozone, General Mills, JPMorganSept 24 (Reuters)-Wall Street securities analysts revised their ratings and price targets for several US-listed companies, including AutoZone, Gene","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL4N45G0KP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRWV","DBX","AMC","BOKU.UK","JPO","AUR","KEY","EWBC","MTB","ALKT","HBAN","IAT","ARCT","CFG","P","SHPP","COLB","DOCK","CRWU","CWBC","IYG","GIS","EFSC","HOPE","IYT","BOKF","CFR","JPMO","ARES","FITB","BCML","CSX","AVBH","AZO","FHN","ALMR","BANC","FIBK","JPM","KBWB","AJG","FLG","CATY","CCL","BAC","CG","MCD","CCNE","LBO","AX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669455661","title":"Alamar Biosciences Inc : Leerink Partners Raises Target Price to $45 from $35","url":"https://stock-news.laohu8.com/highlight/detail?id=2669455661","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669455661?lang=en_us&edition=fundamental","pubTime":"2026-09-24 11:08","pubTimestamp":1790219328,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nFWN45F0R2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668921958","title":"Alamar Biosciences rises 9.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2668921958","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668921958?lang=en_us&edition=fundamental","pubTime":"2026-09-18 22:05","pubTimestamp":1789740343,"startTime":"0","endTime":"0","summary":"Alamar Biosciences (ALMR) is up 9.4%, or $3.01 to $35.02. Published first on TheFly – the ultimate source for real-time, market-moving breaking fin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-rises-9-4-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-rises-9-4-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMR","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664014868","title":"Alamar Biosciences Director Robert P. Ragusa Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2664014868","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664014868?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:26","pubTimestamp":1788467214,"startTime":"0","endTime":"0","summary":"Alamar Biosciences director Robert P. Ragusa files initial beneficial ownership statementAlamar Biosciences director Robert P. Ragusa filed an initial Form 3 beneficial ownership statement dated Sept.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL7VLC9s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMR","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664661318","title":"Alamar Biosciences Appoints Robert Ragusa to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2664661318","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664661318?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:02","pubTimestamp":1788292941,"startTime":"0","endTime":"0","summary":"Alamar Biosciences appoints Robert Ragusa to boardAlamar Biosciences appointed Robert Ragusa to its board, effective Sept. 1, 2026.Ragusa will serve as a Class I director, with an initial term running","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL32sFr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658917839","title":"Alamar Biosciences Price Target Raised to $32.00/Share from $28.00 by Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2658917839","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658917839?lang=en_us&edition=fundamental","pubTime":"2026-08-12 01:51","pubTimestamp":1786470660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALMR/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMR","SF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658122669","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2658122669","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658122669?lang=en_us&edition=fundamental","pubTime":"2026-08-12 01:33","pubTimestamp":1786469637,"startTime":"0","endTime":"0","summary":"Quantum  swung to non-GAAP adjusted net income in fiscal Q1, while revenue exceeded the company's own guidance range, it said late Monday.Shares soared nearly 61% amid a surge in intraday trading volume to over 11.8 million from a daily average of about 1.14 million.NIQ Global Intelligence  reported Q2 adjusted earnings late Monday, swinging from a loss a year earlier. Revenue grew faster than the market had forecast.Shares surged 41% as intraday trading volume jumped to over 6.01 million from a daily average of roughly 1.57 million.Alamar Biosciences  reported a narrower Q2 net loss and sales above consensus late Monday.Shares advanced 34%, with intraday trading volume rising to more than 667,000 from the stock's daily average of about 286,000.Price: 18.65, Change: +6.87, Percent Change: +58.32","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NIQ","BK4170","ALMR","BK4009","BK4602","BK4121","QMCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658912131","title":"Alamar Biosciences Stock Soars, CEO Says Company Is Well-Positioned to Sustain Upcoming Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2658912131","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658912131?lang=en_us&edition=fundamental","pubTime":"2026-08-12 01:25","pubTimestamp":1786469146,"startTime":"0","endTime":"0","summary":"Alamar Biosciences expands its Alzheimer’s data partnership, adds 86,000 samples and reports Q2 sales growth of 82% year-over-year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/earnings/26/08/61120052/alamar-biosciences-stock-soars-ceo-says-company-is-well-positioned-to-sustain-upcoming-momentum","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ODDZ","BK4121","BK4150","ODDS","BETZ","RSI","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658919998","title":"Alamar Biosciences up over 18%, on Track for Record High Close and Record Percent Increase","url":"https://stock-news.laohu8.com/highlight/detail?id=2658919998","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658919998?lang=en_us&edition=fundamental","pubTime":"2026-08-11 22:42","pubTimestamp":1786459320,"startTime":"0","endTime":"0","summary":"Alamar Biosciences, Inc.  is currently at $33.24, up $5.26 or 18.77%--Would be new all-time closing high --Would be largest percent increase on record --Currently up seven of the past nine days--Up 31.09% month-to-date--Would be a new 52-week closing high--Up 74.15% from its 52-week closing low of $19.09 on May 26, 2026--Traded as high as $33.59; new all-time intraday high --Up 20.01% at today's intraday high; largest intraday percent increase on record All data as of 10:40:08 AM ETSource: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658990131","title":"BofA Adjusts Price Target on Alamar Biosciences to $31 From $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2658990131","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658990131?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:13","pubTimestamp":1786450433,"startTime":"0","endTime":"0","summary":"Alamar Biosciences (ALMR) has an average rating of buy and mean price target of $33.40, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658997656","title":"Alamar Biosciences price target raised to $32 from $28 at Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2658997656","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658997656?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:42","pubTimestamp":1786448552,"startTime":"0","endTime":"0","summary":"Stifel raised the firm’s price target on Alamar Biosciences (ALMR) to $32 from $28 and keeps a Buy rating on the shares after the company posted a ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-price-target-raised-to-32-from-28-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-price-target-raised-to-32-from-28-at-stifel-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMR","SF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658998279","title":"U.S. Research Roundup-Accendra Health, Celestica, Sionna Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2658998279","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658998279?lang=en_us&edition=fundamental","pubTime":"2026-08-11 16:10","pubTimestamp":1786435846,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna TherapeuticsAug 11 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, includin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL8N4480HI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASPN","CENX","IYH","AFL","BWMN","AXSM","CODI","BBIO","BBY","CHMI","TGT","ACVA","BKV","LNG","ITA","ACH","SECZ","AGL","ORBX","DRTS","CNC","AFG","ASTS","COP","AAON","ALL","BA","ANF","COR","IEO","CLS","COGT","CRC","BOEU","MO","OILT","IGE","FTXH","TPYP","AAOI","ASTH","ABBV","ALMR","APP","CLBK","CON","RXL","BKD","AMAT","CEVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658952467","title":"Alamar Biosciences Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2658952467","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658952467?lang=en_us&edition=fundamental","pubTime":"2026-08-11 05:38","pubTimestamp":1786397923,"startTime":"0","endTime":"0","summary":"Alamar Biosciences Inc reports results for the quarter ended June 30 - Earnings SummaryAlamar Biosciences IncALMR.OQreported a quarterly adjusted loss of 22 cents per share for the quarter ended June ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL8N44723J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658954341","title":"Alamar Biosciences Outlook FY Revenue $116 Mln-$120 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2658954341","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658954341?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:53","pubTimestamp":1786395213,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nPLXD7W9SP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658039951","title":"Alamar Biosciences reports Q2 EPS (22c), consensus (32c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658039951","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658039951?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:35","pubTimestamp":1786394141,"startTime":"0","endTime":"0","summary":"Reports Q2 revenue $29.4M, consensus $25.94M. “We delivered a strong second quarter with consumable revenue growing nearly 150% year-over-year,” sa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-reports-q2-eps-22c-consensus-32c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-reports-q2-eps-22c-consensus-32c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658951055","title":"Alamar Biosciences sees FY26 revenue $116M-$120M, consensus $113.22M","url":"https://stock-news.laohu8.com/highlight/detail?id=2658951055","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658951055?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:35","pubTimestamp":1786394137,"startTime":"0","endTime":"0","summary":"16:32 EDT Alamar Biosciences (ALMR) sees FY26 revenue $116M-$120M, consensus $113.22M Published first on TheFly – the ultimate source for real-time...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-sees-fy26-revenue-116m-120m-consensus-113-22m-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alamar-biosciences-sees-fy26-revenue-116m-120m-consensus-113-22m-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":72,"code":"91000000","status":"200"}]}}